Adage Capital Partners Gp, L.L.C. Fulcrum Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.9 Billion
Q4 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,000,000 shares of FULC stock, worth $9.06 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,000,000

Previous 2,000,000 50.0%

Holding current value

$9.06 Million

Previous $7.14 Million 97.48%

% of portfolio

0.03%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.97 - $4.84 $2.97 Million - $4.84 Million	1,000,000 Added 50.0%	3,000,000 $14.1 Million
Q3 2024 Nov 14, 2024	BUY	$3.18 - $9.74 $5.41 Million - $16.6 Million	1,700,000 Added 566.67%	2,000,000 $7.14 Million
Q2 2024 Aug 14, 2024	SELL	$5.98 - $9.31 $4.82 Million - $7.51 Million	-806,422 Reduced 72.89%	300,000 $1.86 Million
Q1 2024 May 15, 2024	SELL	$6.7 - $12.0 $2.68 Million - $4.8 Million	-400,000 Reduced 26.55%	1,106,422 $10.4 Million
Q4 2023 Feb 14, 2024	SELL	$3.18 - $6.86 $2.86 Million - $6.17 Million	-900,000 Reduced 37.4%	1,506,422 $10.2 Million
Q3 2023 Nov 14, 2023	BUY	$3.25 - $6.08 $325,000 - $608,000	100,000 Added 4.34%	2,406,422 $10.7 Million
Q2 2023 Aug 14, 2023	BUY	$2.26 - $3.8 $1.13 Million - $1.9 Million	500,000 Added 27.68%	2,306,422 $7.61 Million
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $1.94 Million - $9.6 Million	686,422 Added 61.29%	1,806,422 $5.15 Million
Q4 2022 Feb 14, 2023	SELL	$5.01 - $8.35 $1 Million - $1.67 Million	-200,000 Reduced 15.15%	1,120,000 $8.15 Million
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $5.17 Million - $9.56 Million	1,050,000 Added 388.89%	1,320,000 $10.7 Million
Q2 2022 Aug 15, 2022	SELL	$4.2 - $24.0 $7.06 Million - $40.3 Million	-1,680,000 Reduced 86.15%	270,000 $1.32 Million
Q1 2022 May 16, 2022	BUY	$9.96 - $23.65 $2.29 Million - $5.44 Million	230,000 Added 13.37%	1,950,000 $46.1 Million
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $7.56 Million - $15.4 Million	540,000 Added 45.76%	1,720,000 $30.4 Million
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $8.59 Million - $36.5 Million	1,180,000 New	1,180,000 $33.3 Million

Others Institutions Holding FULC

# of Institutions

130

Shares Held

51.6M

Call Options Held

1.04M

Put Options Held

32.6K

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $157M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Fulcrum Therapeutics, Inc. Transaction History